An Open-label Randomized Phase 1 Study to Investigate the Pharmacokinetics and Pharmacodynamics of Subcutaneous and Intravenous Administrations of Golimumab to Subjects With Rheumatoid Arthritis.
Phase of Trial: Phase I
Latest Information Update: 06 Oct 2017
At a glance
- Drugs Golimumab (Primary) ; Golimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Centocor
- 10 Jun 2017 Biomarkers information updated
- 12 Dec 2011 Results published in the Clinical Therapeutics.
- 27 May 2011 Status changed from not stated to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History